The pathogenesis of epilepsy involves a complex interaction of genetic and environmental factors and nowhere is this more relevant than the use of epigenetic therapies such as inhibitors that target the HDAC enzymes [24]. This evidence concerns the gene HDAC9 and epilepsy.